Public health experts are concerned that, if confirmed, Donald Trump’s choice for secretary of the Department of Health and Human Services (HHS) – Robert F Kennedy Jr – could upend access to pharmaceutical drugs in favor of more experimental treatments.
Kennedy, who the president-elect picked earlier this month, has repeatedly expressed distrust for pharmaceuticals, and criticized the FDA for its “aggressive suppression of psychedelics”. On his podcast, he called the US “the sickest country in the world”, blaming its healthcare system for devoting billions to “the pills and the potions and the powders rather than on actually getting people healthy, building their immune systems”.
